Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-24-001116

Options or other derivatives

  • Chief Executive Officer acquired 1,039,939 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Davidson Michael H. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-01 Grant or award : show line 1 in the form Option (right to buy) +1,039,939 1,039,939 D
Loading xslF345X05/ownership.xml…